NeoGenomics, Inc. Deferred Tax Liabilities, Intangible Assets
NeoGenomics, Inc. (NEO) had Deferred Tax Liabilities, Intangible Assets of $72.50 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-02-17
- 2025-12-31: Deferred Tax Liabilities, Intangible Assets $72.50M.
- 2024-12-31: Deferred Tax Liabilities, Intangible Assets $85.81M.
- 2023-12-31: Deferred Tax Liabilities, Intangible Assets $94.00M.
- 2022-12-31: Deferred Tax Liabilities, Intangible Assets $101.89M.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2025-12-31 | $72.50M 10-K · filed 2026-02-17 |
| 2024-12-31 | $85.81M 10-K · filed 2026-02-17 |
| 2023-12-31 | $94.00M 10-K · filed 2025-02-18 |
| 2022-12-31 | $101.89M 10-K · filed 2024-02-20 |
| 2021-12-31 | $108.59M 10-K · filed 2023-02-24 |
| 2020-12-31 | $29.27M 10-K · filed 2022-02-25 |
| 2019-12-31 | $31.84M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |